In 2013, Mary Lou Polo was given just a week to live. She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo recently celebrated her ...
Immunonutritional status, assessed by PNI and SII, significantly influences ovarian cancer prognosis, affecting survival outcomes and chemotherapy tolerance. High PNI and low SII correlate with longer ...
BERLIN — The combination of pembrolizumab with weekly paclitaxel, with or without bevacizumab, leads to significant improvements in survival outcomes in patients with platinum-resistant recurrent ...
Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...
The World Ovarian Cancer Coalition announced that a groundbreaking international study, "Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Wo ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback